Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive 308-nm Excimer Light During Oral Azithromycin Therapy for Inflammatory Acne Vulgaris
NCT07777952Completed
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial in acne vulgaris (2 arms). Primary endpoint: Change From Baseline in Total Inflammatory-Lesion Count at 8 weeks. Started Oct 2025; status: completed.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07777952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07777952.